Mary M Amon, MD | |
502 2nd St Sw, Suite 1, Willmar, MN 56201-3365 | |
(320) 235-7232 | |
Not Available |
Full Name | Mary M Amon |
---|---|
Gender | Female |
Speciality | Family Practice |
Experience | 33 Years |
Location | 502 2nd St Sw, Willmar, Minnesota |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1518902998 | NPI | - | NPPES |
325101845 | Other | MN | PRIME WEST |
526818400 | Medicaid | MN | |
HP21638 | Other | MN | HEALTH PARTNERS |
01-01066 | Other | MN | MEDICA |
080062303 | Other | MN | RR MEDICARE |
114458 | Other | MN | U CARE |
MR1081007927 | Other | MN | PREFERRED ONE |
1048378 | Other | MN | ARAZ |
6T223AM | Other | MN | BLUE CROSS BLUE SHIELD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 37586 (Minnesota) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Bethesda Home Health | Willmar, MN | Home health agency |
Carris Health Llc | Willmar, MN | Hospital |
Bethesda | Willmar, MN | Nursing home |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Centracare Clinic Southwest Llc | 8426457946 | 141 |
News Archive
St. Jude Children's Research Hospital scientists have rewritten the job description of the protein TopBP1 after demonstrating that it guards early brain cells from DNA damage. Such damage might foreshadow later problems, including cancer.
Precision Antibody announced today its selection by Science Applications International Corporation-Frederick to provide antibody and antigen characterization, including surface plasmon resonance analysis, for the National Cancer Institute's "Clinical Proteomic Technologies for Cancer" initiative. A goal of the CPTC is to develop a standardized resource of very high-quality, renewable reference antibodies generated against cancer-related proteins. The antibodies will be made available to proteomics researchers, along with characterization data and other information intended to support replication and standardization.
RainEarth Inc. (OTC Bulletin Board: RNER; "the Company") announced that in the second quarter of 2009, the Xinhua News Agency publicized the creation of "Opinions of the CPC Central Committee and the State Council on Deepening the Reform of the Medical and Health Care System" ("Opinion").
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 8 days ago
Entity Name | Carris Health Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1598236408 PECOS PAC ID: 7012274228 Enrollment ID: O20190503001162 |
News Archive
St. Jude Children's Research Hospital scientists have rewritten the job description of the protein TopBP1 after demonstrating that it guards early brain cells from DNA damage. Such damage might foreshadow later problems, including cancer.
Precision Antibody announced today its selection by Science Applications International Corporation-Frederick to provide antibody and antigen characterization, including surface plasmon resonance analysis, for the National Cancer Institute's "Clinical Proteomic Technologies for Cancer" initiative. A goal of the CPTC is to develop a standardized resource of very high-quality, renewable reference antibodies generated against cancer-related proteins. The antibodies will be made available to proteomics researchers, along with characterization data and other information intended to support replication and standardization.
RainEarth Inc. (OTC Bulletin Board: RNER; "the Company") announced that in the second quarter of 2009, the Xinhua News Agency publicized the creation of "Opinions of the CPC Central Committee and the State Council on Deepening the Reform of the Medical and Health Care System" ("Opinion").
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 8 days ago
Entity Name | Centracare Clinic Southwest Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1174106264 PECOS PAC ID: 8426457946 Enrollment ID: O20210602002802 |
News Archive
St. Jude Children's Research Hospital scientists have rewritten the job description of the protein TopBP1 after demonstrating that it guards early brain cells from DNA damage. Such damage might foreshadow later problems, including cancer.
Precision Antibody announced today its selection by Science Applications International Corporation-Frederick to provide antibody and antigen characterization, including surface plasmon resonance analysis, for the National Cancer Institute's "Clinical Proteomic Technologies for Cancer" initiative. A goal of the CPTC is to develop a standardized resource of very high-quality, renewable reference antibodies generated against cancer-related proteins. The antibodies will be made available to proteomics researchers, along with characterization data and other information intended to support replication and standardization.
RainEarth Inc. (OTC Bulletin Board: RNER; "the Company") announced that in the second quarter of 2009, the Xinhua News Agency publicized the creation of "Opinions of the CPC Central Committee and the State Council on Deepening the Reform of the Medical and Health Care System" ("Opinion").
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Mary M Amon, MD 502 2nd St Sw, Suite 1, Willmar, MN 56201-3365 Ph: (320) 235-7232 | Mary M Amon, MD 502 2nd St Sw, Suite 1, Willmar, MN 56201-3365 Ph: (320) 235-7232 |
News Archive
St. Jude Children's Research Hospital scientists have rewritten the job description of the protein TopBP1 after demonstrating that it guards early brain cells from DNA damage. Such damage might foreshadow later problems, including cancer.
Precision Antibody announced today its selection by Science Applications International Corporation-Frederick to provide antibody and antigen characterization, including surface plasmon resonance analysis, for the National Cancer Institute's "Clinical Proteomic Technologies for Cancer" initiative. A goal of the CPTC is to develop a standardized resource of very high-quality, renewable reference antibodies generated against cancer-related proteins. The antibodies will be made available to proteomics researchers, along with characterization data and other information intended to support replication and standardization.
RainEarth Inc. (OTC Bulletin Board: RNER; "the Company") announced that in the second quarter of 2009, the Xinhua News Agency publicized the creation of "Opinions of the CPC Central Committee and the State Council on Deepening the Reform of the Medical and Health Care System" ("Opinion").
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 8 days ago
Lee M Haggenjos, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 502 2nd St Sw Ste 1, Willmar, MN 56201 Phone: 320-235-7232 | |
Dr. Raymond J Mellema, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 101 Willmar Ave Sw, Willmar, MN 56201 Phone: 320-231-5000 Fax: 320-231-5067 | |
Dr. Robert M Kaiser, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 101 Willmar Ave Sw, Willmar, MN 56201 Phone: 320-231-5000 Fax: 320-231-5067 | |
Maria Jones Loerzel, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 502 2nd St Sw, Suite 1, Willmar, MN 56201 Phone: 320-235-7232 Fax: 320-231-8602 | |
Shelly M Staska, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Willmar Ave Sw, Willmar, MN 56201 Phone: 320-231-5000 Fax: 320-231-5026 | |
Rachel L Tollefsrud, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 502 2nd St Sw, Suite 1, Willmar, MN 56201 Phone: 320-235-7232 Fax: 320-231-8609 | |
Dr. William E. Hicks, M. D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 101 Willmar Avenue Sw, Willmar, MN 56201 Phone: 320-231-5000 Fax: 320-231-5067 |